{"id":3371,"date":"2020-04-03T10:11:22","date_gmt":"2020-04-03T09:11:22","guid":{"rendered":"https:\/\/ceptonstrategies.com\/en\/?p=3371"},"modified":"2020-04-10T11:31:41","modified_gmt":"2020-04-10T10:31:41","slug":"covidnews-cepton-inato-01","status":"publish","type":"post","link":"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-01\/","title":{"rendered":"COVIDNews CEPTON-INATO #1"},"content":{"rendered":"

Following the spectacular growth of the pandemic, numerous clinical trials have been initiated throughout the world in the past few weeks. CEPTON<\/a>\u00a0and\u00a0INATO<\/a>\u00a0will present you an overview of these trials, updated on a regular basis. Here is the current status, based on the \u00a0ANTICOVID<\/a> \u00a0data.<\/p>\n

By Allan Beke, Phd,\u00a0Matthias Bucher with the support of Inato team<\/div>\n

\"\" \"\"<\/p>\n

<\/p>","protected":false},"excerpt":{"rendered":"

Following the spectacular growth of the pandemic, numerous clinical trials have been initiated throughout the world in the past few weeks. CEPTON\u00a0and\u00a0INATO\u00a0will present you an overview of these trials, updated on a regular basis. Here is the current status, based on the \u00a0ANTICOVID \u00a0data. By Allan Beke, Phd,\u00a0Matthias Bucher with the support of Inato team<\/p>\n","protected":false},"author":4,"featured_media":3364,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[85],"tags":[],"yoast_head":"\nCOVIDNews CEPTON-INATO #1 – Consulting Firm in Pharmaceutical, MedTech & Healthcare<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-01\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"COVIDNews CEPTON-INATO #1 – Consulting Firm in Pharmaceutical, MedTech & Healthcare\" \/>\n<meta property=\"og:description\" content=\"Following the spectacular growth of the pandemic, numerous clinical trials have been initiated throughout the world in the past few weeks. CEPTON\u00a0and\u00a0INATO\u00a0will present you an overview of these trials, updated on a regular basis. Here is the current status, based on the \u00a0ANTICOVID \u00a0data. By Allan Beke, Phd,\u00a0Matthias Bucher with the support of Inato team\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-01\/\" \/>\n<meta property=\"og:site_name\" content=\"Consulting Firm in Pharmaceutical, MedTech & Healthcare\" \/>\n<meta property=\"article:published_time\" content=\"2020-04-03T09:11:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-04-10T10:31:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2020\/04\/markus-spiske-3_SvgDspSTE-unsplash.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"3500\" \/>\n\t<meta property=\"og:image:height\" content=\"2333\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Marc-Olivier B\u00e9vierre\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marc-Olivier B\u00e9vierre\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-01\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-01\/\"},\"author\":{\"name\":\"Marc-Olivier B\u00e9vierre\",\"@id\":\"https:\/\/ceptonstrategies.com\/#\/schema\/person\/188c09921fb1de3e844a50cc08540bf3\"},\"headline\":\"COVIDNews CEPTON-INATO #1\",\"datePublished\":\"2020-04-03T09:11:22+00:00\",\"dateModified\":\"2020-04-10T10:31:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-01\/\"},\"wordCount\":61,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/ceptonstrategies.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-01\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2020\/04\/markus-spiske-3_SvgDspSTE-unsplash.jpg\",\"articleSection\":[\"2020\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-01\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-01\/\",\"url\":\"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-01\/\",\"name\":\"COVIDNews CEPTON-INATO #1 – Consulting Firm in Pharmaceutical, MedTech & Healthcare\",\"isPartOf\":{\"@id\":\"https:\/\/ceptonstrategies.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-01\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-01\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2020\/04\/markus-spiske-3_SvgDspSTE-unsplash.jpg\",\"datePublished\":\"2020-04-03T09:11:22+00:00\",\"dateModified\":\"2020-04-10T10:31:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-01\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-01\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-01\/#primaryimage\",\"url\":\"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2020\/04\/markus-spiske-3_SvgDspSTE-unsplash.jpg\",\"contentUrl\":\"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2020\/04\/markus-spiske-3_SvgDspSTE-unsplash.jpg\",\"width\":3500,\"height\":2333},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-01\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/ceptonstrategies.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"COVIDNews CEPTON-INATO #1\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ceptonstrategies.com\/#website\",\"url\":\"https:\/\/ceptonstrategies.com\/\",\"name\":\"Cepton Stategies Conseil\",\"description\":\"CEPTON is a parisian consulting firm. Our senior consultants are specialized in the pharmaceutical, medtech and healthcare industries\",\"publisher\":{\"@id\":\"https:\/\/ceptonstrategies.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ceptonstrategies.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ceptonstrategies.com\/#organization\",\"name\":\"Cepton Strategies\",\"url\":\"https:\/\/ceptonstrategies.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ceptonstrategies.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2019\/01\/LOGO_CEPTON_CMJN.jpg\",\"contentUrl\":\"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2019\/01\/LOGO_CEPTON_CMJN.jpg\",\"width\":938,\"height\":423,\"caption\":\"Cepton Strategies\"},\"image\":{\"@id\":\"https:\/\/ceptonstrategies.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/strategies-cepton\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/ceptonstrategies.com\/#\/schema\/person\/188c09921fb1de3e844a50cc08540bf3\",\"name\":\"Marc-Olivier B\u00e9vierre\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ceptonstrategies.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/22d508705e6bb61bcefa8f142de4144b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/22d508705e6bb61bcefa8f142de4144b?s=96&d=mm&r=g\",\"caption\":\"Marc-Olivier B\u00e9vierre\"},\"url\":\"https:\/\/ceptonstrategies.com\/en\/author\/marc-olivier\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"COVIDNews CEPTON-INATO #1 – Consulting Firm in Pharmaceutical, MedTech & Healthcare","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-01\/","og_locale":"en_US","og_type":"article","og_title":"COVIDNews CEPTON-INATO #1 – Consulting Firm in Pharmaceutical, MedTech & Healthcare","og_description":"Following the spectacular growth of the pandemic, numerous clinical trials have been initiated throughout the world in the past few weeks. CEPTON\u00a0and\u00a0INATO\u00a0will present you an overview of these trials, updated on a regular basis. Here is the current status, based on the \u00a0ANTICOVID \u00a0data. By Allan Beke, Phd,\u00a0Matthias Bucher with the support of Inato team","og_url":"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-01\/","og_site_name":"Consulting Firm in Pharmaceutical, MedTech & Healthcare","article_published_time":"2020-04-03T09:11:22+00:00","article_modified_time":"2020-04-10T10:31:41+00:00","og_image":[{"width":3500,"height":2333,"url":"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2020\/04\/markus-spiske-3_SvgDspSTE-unsplash.jpg","type":"image\/jpeg"}],"author":"Marc-Olivier B\u00e9vierre","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Marc-Olivier B\u00e9vierre"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-01\/#article","isPartOf":{"@id":"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-01\/"},"author":{"name":"Marc-Olivier B\u00e9vierre","@id":"https:\/\/ceptonstrategies.com\/#\/schema\/person\/188c09921fb1de3e844a50cc08540bf3"},"headline":"COVIDNews CEPTON-INATO #1","datePublished":"2020-04-03T09:11:22+00:00","dateModified":"2020-04-10T10:31:41+00:00","mainEntityOfPage":{"@id":"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-01\/"},"wordCount":61,"commentCount":0,"publisher":{"@id":"https:\/\/ceptonstrategies.com\/#organization"},"image":{"@id":"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-01\/#primaryimage"},"thumbnailUrl":"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2020\/04\/markus-spiske-3_SvgDspSTE-unsplash.jpg","articleSection":["2020"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-01\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-01\/","url":"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-01\/","name":"COVIDNews CEPTON-INATO #1 – Consulting Firm in Pharmaceutical, MedTech & Healthcare","isPartOf":{"@id":"https:\/\/ceptonstrategies.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-01\/#primaryimage"},"image":{"@id":"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-01\/#primaryimage"},"thumbnailUrl":"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2020\/04\/markus-spiske-3_SvgDspSTE-unsplash.jpg","datePublished":"2020-04-03T09:11:22+00:00","dateModified":"2020-04-10T10:31:41+00:00","breadcrumb":{"@id":"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-01\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-01\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-01\/#primaryimage","url":"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2020\/04\/markus-spiske-3_SvgDspSTE-unsplash.jpg","contentUrl":"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2020\/04\/markus-spiske-3_SvgDspSTE-unsplash.jpg","width":3500,"height":2333},{"@type":"BreadcrumbList","@id":"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-01\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ceptonstrategies.com\/en\/"},{"@type":"ListItem","position":2,"name":"COVIDNews CEPTON-INATO #1"}]},{"@type":"WebSite","@id":"https:\/\/ceptonstrategies.com\/#website","url":"https:\/\/ceptonstrategies.com\/","name":"Cepton Stategies Conseil","description":"CEPTON is a parisian consulting firm. Our senior consultants are specialized in the pharmaceutical, medtech and healthcare industries","publisher":{"@id":"https:\/\/ceptonstrategies.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ceptonstrategies.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ceptonstrategies.com\/#organization","name":"Cepton Strategies","url":"https:\/\/ceptonstrategies.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ceptonstrategies.com\/#\/schema\/logo\/image\/","url":"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2019\/01\/LOGO_CEPTON_CMJN.jpg","contentUrl":"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2019\/01\/LOGO_CEPTON_CMJN.jpg","width":938,"height":423,"caption":"Cepton Strategies"},"image":{"@id":"https:\/\/ceptonstrategies.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/strategies-cepton"]},{"@type":"Person","@id":"https:\/\/ceptonstrategies.com\/#\/schema\/person\/188c09921fb1de3e844a50cc08540bf3","name":"Marc-Olivier B\u00e9vierre","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ceptonstrategies.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/22d508705e6bb61bcefa8f142de4144b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/22d508705e6bb61bcefa8f142de4144b?s=96&d=mm&r=g","caption":"Marc-Olivier B\u00e9vierre"},"url":"https:\/\/ceptonstrategies.com\/en\/author\/marc-olivier\/"}]}},"_links":{"self":[{"href":"https:\/\/ceptonstrategies.com\/en\/wp-json\/wp\/v2\/posts\/3371"}],"collection":[{"href":"https:\/\/ceptonstrategies.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ceptonstrategies.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ceptonstrategies.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/ceptonstrategies.com\/en\/wp-json\/wp\/v2\/comments?post=3371"}],"version-history":[{"count":5,"href":"https:\/\/ceptonstrategies.com\/en\/wp-json\/wp\/v2\/posts\/3371\/revisions"}],"predecessor-version":[{"id":3403,"href":"https:\/\/ceptonstrategies.com\/en\/wp-json\/wp\/v2\/posts\/3371\/revisions\/3403"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ceptonstrategies.com\/en\/wp-json\/wp\/v2\/media\/3364"}],"wp:attachment":[{"href":"https:\/\/ceptonstrategies.com\/en\/wp-json\/wp\/v2\/media?parent=3371"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ceptonstrategies.com\/en\/wp-json\/wp\/v2\/categories?post=3371"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ceptonstrategies.com\/en\/wp-json\/wp\/v2\/tags?post=3371"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}